{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:37:07Z","timestamp":1790685427322,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jacl.2018.03.092","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T14:45:19Z","timestamp":1522766719000},"page":"1027-1038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Posttranslational modification of proprotein convertase subtilisin\/kexin type 9 is differentially regulated in response to distinct cardiometabolic treatments as revealed by targeted proteomics"],"prefix":"10.1016","volume":"12","author":[{"given":"Marie-Soleil","family":"Gauthier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhier","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e","family":"Champagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Tessier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Faubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Chabot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Y.","family":"Garneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Rabasa-Lhoret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil G.","family":"Seidah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Ridker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Genest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Coulombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2018.03.092_bib1","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation","volume":"100","author":"Seidah","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacl.2018.03.092_bib2","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2018.03.092_bib3","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.114.301621","article-title":"PCSK9: a key modulator of cardiovascular health","volume":"114","author":"Seidah","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jacl.2018.03.092_bib4","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1373\/clinchem.2011.165191","article-title":"Novel loss-of-function PCSK9 variant is associated with low plasma LDL cholesterol in a French-Canadian family and with impaired processing and secretion in cell culture","volume":"57","author":"Mayne","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2018.03.092_bib5","doi-asserted-by":"crossref","first-page":"33745","DOI":"10.1074\/jbc.M112.399725","article-title":"Loss- and gain-of-function PCSK9 variants: cleavage specificity, dominant negative effects, and low density lipoprotein receptor (LDLR) degradation","volume":"287","author":"Benjannet","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2018.03.092_bib6","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1074\/jbc.M110.192104","article-title":"In\u00a0vivo evidence that furin from hepatocytes inactivates PCSK9","volume":"286","author":"Essalmani","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2018.03.092_bib7","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1194\/jlr.M049346","article-title":"Isolation and characterization of the circulating truncated form of PCSK9","volume":"55","author":"Han","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2018.03.092_bib8","doi-asserted-by":"crossref","first-page":"30561","DOI":"10.1074\/jbc.M606495200","article-title":"The proprotein convertase (PC) PCSK9 is inactivated by furin and\/or PC5\/6A: functional consequences of natural mutations and post-translational modifications","volume":"281","author":"Benjannet","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2018.03.092_bib9","doi-asserted-by":"crossref","first-page":"43482","DOI":"10.1074\/jbc.M112.380618","article-title":"Furin-cleaved PCSK9 is active and modulates LDL receptor and serum cholesterol levels","volume":"287","author":"Lipari","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2018.03.092_bib10","doi-asserted-by":"crossref","first-page":"48865","DOI":"10.1074\/jbc.M409699200","article-title":"NARC-1\/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol","volume":"279","author":"Benjannet","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2018.03.092_bib11","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1073\/pnas.0712064105","article-title":"Molecular basis for LDL receptor recognition by PCSK9","volume":"105","author":"Kwon","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacl.2018.03.092_bib12","doi-asserted-by":"crossref","first-page":"40965","DOI":"10.1074\/jbc.M110.154815","article-title":"Effects of the Prosegment and pH on the Activity of PCSK9: evidence for additional processing events","volume":"285","author":"Benjannet","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2018.03.092_bib13","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1194\/jlr.M061903","article-title":"Proteolytic cleavage of antigen extends the durability of an anti-PCSK9 monoclonal antibody","volume":"56","author":"Schroeder","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2018.03.092_bib14","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1111\/j.1742-4658.2008.06495.x","article-title":"PCSK9 is phosphorylated by a Golgi casein kinase-like kinase ex\u00a0vivo and circulates as a phosphoprotein in humans","volume":"275","author":"Dewpura","year":"2008","journal-title":"FEBS J"},{"key":"10.1016\/j.jacl.2018.03.092_bib15","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.cell.2015.05.028","article-title":"A single kinase generates the majority of the secreted phosphoproteome","volume":"161","author":"Tagliabracci","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jacl.2018.03.092_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymeth.2015.03.003","article-title":"A semi-automated mass spectrometric immunoassay coupled to selected reaction monitoring (MSIA-SRM) reveals novel relationships between circulating PCSK9 and metabolic phenotypes in patient cohorts","volume":"81","author":"Gauthier","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.jacl.2018.03.092_bib17","series-title":"Pcsk9 proteins, fragments thereof and methods of modulating pcsk9 phosphorylation and low density lipoprotein (ldlr) degradation","author":"Mayne","year":"2008"},{"key":"10.1016\/j.jacl.2018.03.092_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/1354750X.2016.1201533","article-title":"Development of quantitative mass spectrometric immunoassay for serum amyloid A","volume":"21","author":"Trenchevska","year":"2016","journal-title":"Biomarkers"},{"key":"10.1016\/j.jacl.2018.03.092_bib19","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1074\/mcp.M114.047621","article-title":"Gamma-carboxylation and fragmentation of osteocalcin in human serum defined by mass spectrometry","volume":"14","author":"Rehder","year":"2015","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jacl.2018.03.092_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymeth.2015.02.020","article-title":"Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoforms","volume":"81","author":"Trenchevska","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.jacl.2018.03.092_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.clinbiochem.2012.12.019","article-title":"Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum","volume":"46","author":"Krastins","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jacl.2018.03.092_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.diabet.2016.10.004","article-title":"Evolution of subcutaneous adipose tissue fibrosis after bariatric surgery","volume":"43","author":"Chabot","year":"2017","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jacl.2018.03.092_bib23","doi-asserted-by":"crossref","first-page":"E2518","DOI":"10.1210\/jc.2014-1662","article-title":"Increased subcutaneous adipose tissue expression of genes involved in glycerolipid-fatty acid cycling in obese insulin-resistant versus -sensitive individuals","volume":"99","author":"Gauthier","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2018.03.092_bib24","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2018.03.092_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1373\/clinchem.2011.172932","article-title":"Proprotein convertase subtilisin\/kexin type 9 concentrations, and LDL cholesterol response: the JUPITER Trial","volume":"58","author":"Awan","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2018.03.092_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.jacl.2018.03.092_bib27","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.amjmed.2016.02.004","article-title":"Changes in lipid profile of obese patients following contemporary bariatric surgery: a meta-analysis","volume":"129","author":"Heffron","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.jacl.2018.03.092_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.amjmed.2008.09.041","article-title":"Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis","volume":"122","author":"Buchwald","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.jacl.2018.03.092_bib29","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1001\/jama.2014.5988","article-title":"Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications","volume":"311","author":"Sjostrom","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2018.03.092_bib30","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/humupd\/dmx012","article-title":"Prevalence of \u201cobesity-associated gonadal dysfunction\u201d in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis","volume":"23","author":"Escobar-Morreale","year":"2017","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jacl.2018.03.092_bib31","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1111\/febs.13309","article-title":"beta-Estradiol results in a proprotein convertase subtilisin\/kexin type 9-dependent increase in low-density lipoprotein receptor levels in human hepatic HuH7 cells","volume":"282","author":"Starr","year":"2015","journal-title":"FEBS J"},{"key":"10.1016\/j.jacl.2018.03.092_bib32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/met.2017.0027","article-title":"Association between plasma proprotein convertase subtilisin\/kexin type 9 and the presence of metabolic syndrome in a predominantly rural-based sub-saharan African population","volume":"15","author":"Paquette","year":"2017","journal-title":"Metab Syndr Relat Disord"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418301971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418301971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:33:26Z","timestamp":1761831206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287418301971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1933287418301971"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2018.03.092","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Posttranslational modification of proprotein convertase subtilisin\/kexin type 9 is differentially regulated in response to distinct cardiometabolic treatments as revealed by targeted proteomics","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2018.03.092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}